Literature DB >> 25030285

Fluorodeoxyglucose positron emission tomography/magnetic resonance imaging: current status, future aspects.

Rajan Rakheja1, Hersh Chandarana2, Fabio Ponzo2, Alexandra L Seltzer2, Luis S Beltran2, Christian Geppert3, Kent P Friedman2.   

Abstract

Simultaneous positron emission tomography (PET)/magnetic resonance (MR) imaging is a promising novel technology for oncology diagnosis and staging and neurologic and cardiac applications. Our institution's current research protocol results in a total imaging time of approximately 45 to 70 minutes with simultaneous PET/MR imaging, making this a feasible total body imaging protocol. Further development of MR-based attenuation correction will improve PET quantification. Quantitatively accurate multiparametric PET/MR data sets will likely improve diagnosis of disease and help guide and monitor the therapies for individualized patient care.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Apparent diffusion coefficient; Bone metastases; Dementia; Lung cancer; Magnetic resonance; Positron emission tomography; Sodium fluoride

Mesh：

Substances：

Year:  2013        PMID： 25030285     DOI： 10.1016/j.cpet.2013.10.007

Source DB:  PubMed          Journal:  PET Clin        ISSN： 1556-8598


  5 in total

Review 1.  PET/MRI of central nervous system: current status and future perspective.

Authors:  Zhen Lu Yang; Long Jiang Zhang
Journal:  Eur Radiol       Date:  2016-01-15       Impact factor: 5.315

Review 2.  Imaging and evaluation of patients with high-risk prostate cancer.

Authors:  Marc A Bjurlin; Andrew B Rosenkrantz; Luis S Beltran; Roy A Raad; Samir S Taneja
Journal:  Nat Rev Urol       Date:  2015-10-20       Impact factor: 14.432

Review 3.  Disease-specific cardiovascular positron emission tomography/magnetic resonance imaging: a brief review of the current literature.

Authors:  Jeffrey M C Lau; Jie Zheng
Journal:  Quant Imaging Med Surg       Date:  2016-06

4.  Bone biopsy protocol for advanced prostate cancer in the era of precision medicine.

Authors:  Verena Sailer; Marc H Schiffman; Myriam Kossai; Joanna Cyrta; Shaham Beg; Brian Sullivan; Bradley B Pua; Kyungmouk Steve Lee; Adam D Talenfeld; David M Nanus; Scott T Tagawa; Brian D Robinson; Rema A Rao; Chantal Pauli; Rohan Bareja; Luis S Beltran; Alexandros Sigaras; Kenneth Wa Eng; Olivier Elemento; Andrea Sboner; Mark A Rubin; Himisha Beltran; Juan Miguel Mosquera
Journal:  Cancer       Date:  2017-12-19       Impact factor: 6.860

Review 5.  Current Status of Hybrid PET/MRI in Oncologic Imaging.

Authors:  Andrew B Rosenkrantz; Kent Friedman; Hersh Chandarana; Amy Melsaether; Linda Moy; Yu-Shin Ding; Komal Jhaveri; Luis Beltran; Rajan Jain
Journal:  AJR Am J Roentgenol       Date:  2015-10-22       Impact factor: 3.959
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.